(Q50970534)

26 March 2018

title

Gastrointestinal cancer after treatment of Hodgkin's disease. (English)

1 reference

26 March 2018

author name string

Birdwell SH

1

1 reference

26 March 2018

Hancock SL

2

1 reference

26 March 2018

Varghese A

3

1 reference

26 March 2018

Cox RS

4

1 reference

26 March 2018

Hoppe RT

5

1 reference

26 March 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

26 March 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

26 March 2018

volume

37

1 reference

26 March 2018

page(s)

67-73

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Incidence of second cancers in patients treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Solid cancer risk after treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Linitis plastica after Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Cancer following radiotherapy for peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Breast cancer after treatment of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Incidence of second primary cancer following testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Analysis of relative survival and proportional mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

The treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

The continuing challenge of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Thoracic irradiation in Hodgkin's disease: disease control and long-term complications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Risk of second cancers after treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

Second cancer risk following Hodgkin's disease: a 20-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900489-0

7 January 2021

10.1016/S0360-3016(96)00489-0

Identifiers

DOI

1 reference

26 March 2018

PubMed ID

9054878

1 reference

26 March 2018